Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Floege

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Der Internist|November 25, 2003
[Therapy and prophylaxis of renal failure]V M Brandenburg, B Heintz, J Floege
Der Internist|March 1, 1995
[Primary glomerulonephritis. Classification and clinicopathologic correlates]J Floege, R Brunkhorst, H J Gröne
Journal of Nephrology|August 10, 1999
Rodent models of nephropathy associated with type II diabetesU Janssen, A O Phillips, J Floege
Der Internist|March 23, 1999
[Long-term management of dialysis patients. I. Hypertension and anemia]J Schäffer, J Floege, K M Koch
Contributions to Nephrology|January 1, 1995
Clinical aspects of dialysis-related amyloidosisJ Schäffer, J Floege, K M Koch
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2006
NDT contributes to a collection of 100 seminal papers published by Oxford University PressD C Wheeler, J Floege, N Lameire
Der Internist|September 26, 2018
[What is certain in the treatment of glomerulonephritis?]J Floege, P Boor, M J Moeller
The Clinical Investigator|September 1, 1992
Mesangial cells in the pathogenesis of progressive glomerular disease in animal modelsJ Floege, R J Johnson, W G Couser
Kidney International|February 1, 1994
Glomerular cells in vitro versus the glomerulus in vivoJ Floege, H R Radeke, R J Johnson
Nephron|January 1, 1988
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?J Floege, C Granolleras, K M Koch, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Der Internist|November 25, 2003
[Therapy and prophylaxis of renal failure]V M Brandenburg, B Heintz, J Floege
Der Internist|March 1, 1995
[Primary glomerulonephritis. Classification and clinicopathologic correlates]J Floege, R Brunkhorst, H J Gröne
Journal of Nephrology|August 10, 1999
Rodent models of nephropathy associated with type II diabetesU Janssen, A O Phillips, J Floege
Der Internist|March 23, 1999
[Long-term management of dialysis patients. I. Hypertension and anemia]J Schäffer, J Floege, K M Koch
Contributions to Nephrology|January 1, 1995
Clinical aspects of dialysis-related amyloidosisJ Schäffer, J Floege, K M Koch
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2006
NDT contributes to a collection of 100 seminal papers published by Oxford University PressD C Wheeler, J Floege, N Lameire
Der Internist|September 26, 2018
[What is certain in the treatment of glomerulonephritis?]J Floege, P Boor, M J Moeller
The Clinical Investigator|September 1, 1992
Mesangial cells in the pathogenesis of progressive glomerular disease in animal modelsJ Floege, R J Johnson, W G Couser
Kidney International|February 1, 1994
Glomerular cells in vitro versus the glomerulus in vivoJ Floege, H R Radeke, R J Johnson
Nephron|January 1, 1988
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?J Floege, C Granolleras, K M Koch, et al.
Pageof 16